Hyundai Bioscience Co., Ltd. (KOSDAQ:A048410), CnPharm Co., Ltd. and Yeonjin Kim agreed to acquire 32.47% stake in ADM Korea Inc. (KOSDAQ:A187660) from Mobiis Co., Ltd. (KOSDAQ:A250060) for KRW 31 billion on March 11, 2024. Transaction is expected to May 20, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,550 KRW | 0.00% | +1.72% | +83.18% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
20,650 KRW | -1.67% | +1.98% | 613M | ||
3,775 KRW | -1.31% | +7.09% | 89.52M | ||
3,550 KRW | 0.00% | +1.72% | 55.02M | ||
1st Jan change | Capi. | |
---|---|---|
+83.18% | 55.02M | |
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |
- Stock Market
- Equities
- A187660 Stock
- News ADM Korea Inc.
- Hyundai Bioscience Co., Ltd., CnPharm Co., Ltd. and Yeonjin Kim agreed to acquire 32.47% stake in ADM Korea Inc. from Mobiis Co., Ltd. for KRW 31 billion.